CliffBio
small molecule

LANOXIN

DIGOXIN

Loss of exclusivity—loss of exclusivity
CompanyAZURITY PHARMACEUTICALS SWITZERLAND GMBH

Drug detail

Brand nameLANOXIN
Active ingredientDIGOXIN
Strength0.25MG/ML
Dosage formINJECTABLE
RouteINJECTION
ModalitySmall molecule
Marketing statusRX

More from AZURITY PHARMACEUTICALS SWITZERLAND GMBH

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.

LANOXIN patent cliff — loss of exclusivity — | CliffBio